PS2-21: The Return on Investment of a Laboratory Program to Decrease Adverse Events of ACE Inhibitors and ARBs

Introduction: The efficiency of patient safety interventions is not well studied, including laboratory monitoring for drug therapy. Although 30% of patients receiving inhibitors of rennin-angiotensin system (RAS i.e. ACEI and ARB medications) are not monitored according to guidelines, knowledge of t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Smith, David H, Raebel, Marsha A, Chan, K Arnold, Johnson, Eric S, Petrik, Amanda, Weinstein, Jessica, Yang, Xiuhai, Feldstein, Adrianne
Formato: Artigo
Idioma:Inglês
Publicado em: Marshfield Clinic 2010
Assuntos:
SELECTED ABSTRACTS - HMORN 2009: Pharmacoepidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2842386/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.8.1.59
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados